BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 27112344)

  • 1. Can a pharmacy intervention improve the metabolic risks of mental health patients? Evaluation of a novel collaborative service.
    Maulavizada H; Emmerton L; Hattingh HL
    BMC Health Serv Res; 2016 Apr; 16():146. PubMed ID: 27112344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
    Hattingh HL; Kelly F; Fowler J; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consolidating innovative practice models: The case for obstructive sleep apnea services in Australian pharmacies.
    Hanes CA; Wong KK; Saini B
    Res Social Adm Pharm; 2015; 11(3):412-27. PubMed ID: 25262387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nurse practitioners: an insight into their integration into Australian community pharmacies.
    McMillan SS; Emmerton L
    Res Social Adm Pharm; 2013; 9(6):975-80. PubMed ID: 23062783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From community pharmacy to healthy living pharmacy: positive early experiences from Portsmouth, England.
    Brown D; Portlock J; Rutter P; Nazar Z
    Res Social Adm Pharm; 2014; 10(1):72-87. PubMed ID: 23731701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacist health coaching in Australian community pharmacies: What do pharmacy professionals think?
    Singh HK; Kennedy GA; Stupans I
    Health Soc Care Community; 2020 Jul; 28(4):1190-1198. PubMed ID: 32020737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of chronic disease management algorithms in Australian community pharmacies.
    Morrissey H; Ball P; Jackson D; Pilloto L; Nielsen S
    Res Social Adm Pharm; 2015; 11(2):176-96. PubMed ID: 25035062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practice change in community pharmacy: using change-management principles when implementing a pharmacy asthma management service in NSW, Australia.
    Feletto E; Lui GW; Armour C; Saini B
    Int J Pharm Pract; 2013 Feb; 21(1):28-37. PubMed ID: 23301531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients' perceptions of a pharmacist-managed weight management clinic in a community setting.
    O'Neal KS; Crosby KM
    Res Social Adm Pharm; 2013; 9(1):129-36. PubMed ID: 22695218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Australian mental health consumers and carers expect more health management information from community pharmacy.
    Fejzic J; Knox K; Hattingh HL; Mey A; McConnell D; Wheeler AJ
    Int J Pharm Pract; 2017 Dec; 25(6):454-462. PubMed ID: 28303618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of a medication therapy management collaborative within a pediatric health system.
    Sneed G; Kappeler K; Gilmore T; Kuhn C
    J Am Pharm Assoc (2003); 2018; 58(4S):S114-S119. PubMed ID: 29871801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pharmacy carer support service: obtaining new insight into carers in the community.
    McMillan SS; King MA; Stapleton H; Sav A; Kelly F; Wheeler AJ
    Int J Pharm Pract; 2019 Feb; 27(1):34-44. PubMed ID: 29732644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring an increased role for Australian community pharmacy in mental health professional service delivery: evaluation of the literature
    Hattingh HL; Scahill S; Fowler JL; Wheeler AJ
    J Ment Health; 2016 Dec; 25(6):550-559. PubMed ID: 26607639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing and testing evidence-based weight management in Australian pharmacies: A Healthier Life Program.
    Um IS; Krass I; Armour C; Gill T; Chaar BB
    Int J Clin Pharm; 2015 Oct; 37(5):822-33. PubMed ID: 25920908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of hypertension in an Australian community pharmacy setting - patients' beliefs and perspectives.
    Bajorek BV; LeMay KS; Magin PJ; Roberts C; Krass I; Armour CL
    Int J Pharm Pract; 2017 Aug; 25(4):263-273. PubMed ID: 27633151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supporting patients with mental illness: Deconstructing barriers to community pharmacist access.
    Calogero S; Caley CF
    J Am Pharm Assoc (2003); 2017; 57(2):248-255. PubMed ID: 28153705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A qualitative study exploring community pharmacists' awareness of, and contribution to, self-care support in the management of long-term conditions in the United Kingdom.
    Ogunbayo OJ; Schafheutle EI; Cutts C; Noyce PR
    Res Social Adm Pharm; 2015; 11(6):859-79. PubMed ID: 25677228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the implementation of a novel community pharmacist-led support service for people living with severe and persistent mental illness.
    Ng R; El-Den S; Collins JC; Stewart V; McMillan SS; Hu J; Wheeler AJ; O'Reilly CL
    Res Social Adm Pharm; 2024 Jun; 20(6):113-122. PubMed ID: 38467520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Australian mental health consumers' and carers' experiences of community pharmacy service.
    Knox K; Kelly F; Mey A; Hattingh L; Fowler JL; Wheeler AJ
    Health Expect; 2015 Dec; 18(6):2107-20. PubMed ID: 24612376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.